Non-Current Liabilities
Total Liabilities
Bristol-Myers Squibb Total Liabilities increased by 1.4% to $78.29B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $76.47B to $78.29B. Over 4 years (FY 2020 to FY 2024), Total Liabilities shows relatively stable performance with a -1.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
A high level of total liabilities relative to equity indicates a more leveraged capital structure and higher financial risk.
Detailed definition
The aggregate of all current and non-current debts and obligations owed by the company to external parties. It represent...
Peer comparison
Analyzed alongside Total Assets to determine the Debt-to-Asset ratio, which is a standard measure of solvency across all industries.
Metric ID:
total_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.92B | $73.61B | $73.31B | $71.39B | $67.70B | $65.46B | $65.70B | $62.40B | $61.46B | $62.20B | $65.67B | $82.48B | $77.58B | $76.47B | $76.22B | $74.98B | $77.19B | $78.29B |
| QoQ Change | — | -0.4% | -0.4% | -2.6% | -5.2% | -3.3% | +0.4% | -5.0% | -1.5% | +1.2% | +5.6% | +25.6% | -5.9% | -1.4% | -0.3% | -1.6% | +2.9% | +1.4% |
| YoY Change | — | — | — | — | -8.4% | -11.1% | -10.4% | -12.6% | -9.2% | -5.0% | -0.0% | +32.2% | +26.2% | +22.9% | +16.1% | -9.1% | -0.5% | +2.4% |
Range$61.46B – $82.48B
CAGR+1.4%
Avg YoY Growth+2.4%
Median YoY Growth-2.7%
Current Streak2 quarters growth
Total Liabilities at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total liabilities?
- Bristol-Myers Squibb (BMY) reported total liabilities of $78.29B in Q3 2025.
- How has Bristol-Myers Squibb's total liabilities changed year-over-year?
- Bristol-Myers Squibb's total liabilities increased by 2.4% year-over-year, from $76.47B to $78.29B.
- What is the long-term trend for Bristol-Myers Squibb's total liabilities?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's total liabilities has grown at a -1.4% compound annual growth rate (CAGR), from $80.60B to $76.22B.
- What does total liabilities mean?
- The total amount of money the company owes to everyone, both now and in the future.